Drug-Induced Interstitial Lung Disease after Anthracycline-Combined Chemotherapy for Breast Cancer: A Case Report and Literature Review
Drug-induced interstitial lung disease (DILD) has been occasionally reported with various causative drugs. In the context of breast cancer, anthracycline infrequently causes pulmonary adverse events. We report a 67-year-old woman with cT2N0M0 triple-negative breast cancer who received neoadjuvant ch...
Saved in:
Main Authors: | Hideko Hoshina, Hiroyuki Takei |
---|---|
Format: | article |
Language: | EN |
Published: |
Karger Publishers
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/8b7db9562aaf4b3c85a16ae8741a0fcc |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Skin Rash and Interstitial Pneumonia Can Be a Fatal Combination: A Rare Case of Anti-Melanoma Differentiation-Associated Gene 5 (MDA5)-Associated Interstitial Lung Disease
by: Giorgia Borio, et al.
Published: (2021) -
Clopidogrel-Induced Interstitial Lung Disease: A Case Report
by: An J, et al.
Published: (2021) -
Current Perspectives On Emerging Biomarkers For Rheumatoid Arthritis-Associated Interstitial Lung Disease
by: Amigues I, et al.
Published: (2019) -
Clinical Case of Idiopathic Interstitial Pneumonia: Expert Approaches
by: V. M. Karetnikova, et al.
Published: (2019) -
Interstitial lung abnormalities – current knowledge and future directions
by: Gisli Thor Axelsson, et al.
Published: (2021)